INS and myotonic dystrophy type 2: In the EUROASPIRE I–V study, 29% of all patients reported having DM2; of them, GLT was taken as follows: insulin, 32%; oral GLT, 74%; and 16% of the examined patients did not assess their blood glucose levels after discharge [15].